Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AXICHEM AS
AS
Active
Org 923630279
Kleppevegen 39, 5300 Kleppestø
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2019
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 1,7M
-19% vs 2024
EBITDA margin
6.2%
0% vs 2024
Equity ratio
64.5%
Financial strength
Net profit 2025
NOK 75K
+6% vs 2024
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 1,7M
-19%
EBITDA
NOK 105K
+0%
Net profit
NOK 75K
+6%
Total assets
NOK 652K
-3%
Equity
NOK 420K
+22%
Employees
2
—
Company information
Legal name
AXICHEM AS
Org number
923630279
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. oktober 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Daglig leder alene.
Company purpose
Levere konsulenttjenester til konsernselskap, utvikle og selge biokjemiske og kjemiske produkter samt å drive enhver annen dermed forenlig virksomhet.
Contact
Address
Kleppevegen 39, 5300 Kleppestø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Askøy
All Norway companies
Revenue
NOK millions
0M
1M
1M
2M
2M
0M
2019
1M
2020
1M
2021
2M
2022
2M
2023
2M
2024
2M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2019
2020
2021
2022
2023
2024
2025
Revenue
196
1 071
1 389
1 938
1 913
2 088
1 695
Staff expenses
−105
−752
−778
−914
−856
−868
−755
EBITDA
17
48
149
63
64
105
105
Depreciation & amort.
−0
−0
−0
−0
−0
−0
−0
EBIT
17
48
149
63
64
105
105
Net financials
0
−15
12
−0
0
−0
−0
Profit before tax
17
34
161
63
64
104
104
Tax
2
7
35
25
25
33
29
Net profit
14
26
126
39
39
71
75
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
2023
2024
2025
Total assets
165
299
481
566
581
669
652
Equity
44
70
196
235
274
345
420
Long-term debt
0
0
0
0
0
0
0
Short-term debt
121
228
285
332
308
324
231
Total debt
121
228
285
332
308
324
231
Financial ratios
5-year trend
EBITDA margin
6.2%
This company
15.8%
Market median
-61% vs market
2019
2025
Equity ratio
64.5%
This company
38.2%
Market median
+69% vs market
2019
2025
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
2019
2025
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
2019
2025
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
2019
2025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2019
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-08-29 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LA
Lucas Altepost
Chief Executive Officer
Chief Executive Officer
2019
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
NT
Nils Torsten Helsing
Chairman
2019
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Axichem Ab
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of AXICHEM AS also hold positions in
0
other companies.
Person
Role here
Other companies
Lucas Altepost
Chief Executive Officer
0 companies
Nils Torsten Helsing
Chairman
0 companies